FDA Adverse Event
Malfunction
Summary report: N
DRUG ELUTING PERMANENT RIGHT VENTRICULAR OR ATRIAL PACEMAKER ELECTRODES
MDR report key: 17597600
·
Received August 22, 2023
Report
- Report Number
- 2124215-2023-45230
- Event Type
- Malfunction
- Date Received
- August 22, 2023
- Date of Event
- July 6, 2023
- Report Date
- August 22, 2023
- Manufacturer
- BOSTON SCIENTIFIC CORPORATION
- Product Code
- NVN
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- US
- Reporter Occupation
- OTHER
Narratives
Description of Event or Problem · 0
IT WAS REPORTED THAT THE PATIENT WITH THIS BRADY LEAD WAS HAVING PREMATURE ATRIAL CONTRACTION/COMPLEX (PAC). THE LEAD SENSITIVITY WAS PROGRAMMED TO 0.3 MILLI VOLTS FROM 0.45 MILLI VOLTS, PACED ATRIO-VENTRICULAR DELAY (PAV) TO 220, MODE WAS CHANGED TO DDIR, AND MITRAL VALVE PROLAPSE (MVP) WAS TURNED OFF. THIS LEAD REMAINS IN SERVICE. NO ADVERSE PATIENT EFFECTS WERE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 306980 | DRUG ELUTING PERMANENT RIGHT VENTRICULAR OR ATRIAL PACEMAKER ELECTRODES | NVN | BOSTON SCIENTIFIC CORPORATION | 4269 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Unknown |